Yes, you can and should administer meningococcal, Quadracel, and varicella vaccines together at the same visit for a 7-year-old child.
General Principle of Simultaneous Administration
The CDC explicitly recommends that simultaneously administering all vaccines for which a child is eligible is critical for ensuring complete immunization at the appropriate age. 1, 2 Extensive clinical experience demonstrates that simultaneous administration of live and inactivated vaccines produces seroconversion rates and adverse reaction rates similar to separate administration. 1, 2
Specific Evidence for This Combination
Meningococcal with Varicella
- Clinical trials involving children demonstrated that meningococcal conjugate vaccine (MenACWY-CRM) administered concomitantly with measles, mumps, rubella, and varicella vaccine (MMRV) was well-tolerated without safety concerns. 3
- Robust immune responses to all components of both vaccines were produced, and all criteria for non-inferiority were met. 3
- No increased reactogenicity was observed with meningococcal vaccine plus MMRV compared with MMRV alone, and there were no study-related serious adverse events. 3
DTaP-Containing Vaccines (Quadracel) with Varicella
- Clinical trials involving 1,913 children showed that varicella-containing vaccines administered concomitantly with DTaP, Hib, and hepatitis B vaccines produced comparable seroconversion rates and antibody titers. 2
- A phase III study of 4,011 children aged 4-6 years demonstrated that DTaP-IPV (the components in Quadracel) co-administered with varicella vaccine showed non-inferior immune responses and similar reactogenicity profiles. 4
- Single-antigen varicella vaccine may be administered simultaneously with vaccines containing diphtheria, tetanus, and pertussis antigens. 2
All Three Together
- PCV13 (pneumococcal vaccine) has been administered concurrently with vaccines containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and varicella with no adverse effects on immunogenicity or safety. 1
- This establishes precedent that multiple vaccines including DTaP-IPV components and varicella can be given together safely. 1
Critical Timing Considerations
No spacing is required between inactivated vaccines (meningococcal conjugate and Quadracel) and live vaccines (varicella). 1, 2, 5 The 4-week spacing rule only applies when two live parenteral vaccines are given separately (not simultaneously). 2, 5
Practical Administration Guidelines
- Administer each vaccine at separate anatomic sites using different syringes. 1, 2, 5
- Quadracel: 0.5 mL intramuscularly 1
- Meningococcal conjugate: 0.5 mL intramuscularly 1
- Varicella: 0.5 mL subcutaneously 2, 5
- Never mix vaccines in the same syringe unless specifically FDA-approved for mixing. 1, 2, 5
Benefits of Simultaneous Administration
- Increases vaccination coverage by reducing missed opportunities. 2, 5
- Approximately one-third of measles cases among unvaccinated preschool children could have been prevented if vaccines had been given simultaneously during prior visits. 2, 6
- Reduces clinic visits required, improving patient compliance. 5
- Provides timely protection against all diseases without delay. 5
- Simultaneous administration is particularly critical when uncertainty exists about whether the child will return for future doses. 2, 5
Common Pitfalls to Avoid
- Do not delay any vaccine unnecessarily—there is no medical benefit to spacing these vaccines apart. 2, 5
- Do not confuse the live-to-live vaccine spacing rule with inactivated-to-live administration—both Quadracel and meningococcal vaccines are inactivated and require no spacing from varicella. 2, 5
- Delaying vaccines increases the risk of missed opportunities and leaves children unprotected. 2
- Use the full 0.5 mL dose of each vaccine; do not use reduced volumes. 5
Contraindications to Consider
Defer vaccination if the child has: 1
- Moderate to severe acute illness with or without fever 1
- Severe allergic reaction (anaphylaxis) to any vaccine component 1
- Altered immunity or immunodeficiency (for varicella vaccine specifically) 1
- Recent receipt of antibody-containing blood products (affects varicella vaccine timing) 1